Abstract
Body weight is determined by the balance between energy intake and energy expenditure. When energy intake exceeds energy expenditure, the surplus energy is stored as fat in the adipose tissue, which causes its expansion and may even lead to the development of obesity. Thus, there is a growing interest to develop dietary interventions that could reduce the current obesity epidemic. In this regard, data from a number of in vivo and in vitro studies suggest that the branched-chain amino acid leucine influences energy balance. However, this has not been consistently reported. Here, we review the literature related to the effects of leucine on energy intake, energy expenditure and lipid metabolism as well as its effects on the cellular activity in the brain (hypothalamus) and in peripheral tissues (gastro-intestinal tract, adipose tissue, liver and muscle) regulating the above physiological processes. Moreover, we discuss how obesity may influence the actions of this amino acid.
Similar content being viewed by others
References
Arase K, York DA, Shimizu H et al (1988) Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am J Physiol 255:E255–E259
Azzara AV, Sokolnicki JP, Schwartz GJ (2002) Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition. Physiol Behav 77:411–416
Backus RC, Howard KA, Rogers QR (1997) The potency of dietary amino acids in elevating plasma cholecystokinin immunoreactivity in cats is related to amino acid hydrophobicity. Regul Pept 72:31–40
Balage M, Dardevet D (2010) Long-term effects of leucine supplementation on body composition. Curr Opin Clin Nutr 13:265–270
Bartness TJ, Song CK (2007) Brain–adipose tissue neural crosstalk. Physiol Behav 91:343–351
Bjorkman MP, Pilvi TK, Kekkonen RA et al (2011) Similar effects of leucine rich and regular dairy products on muscle mass and functions of older polymyalgia rheumatica patients: A randomized crossover trial. J Nutr Health Aging 15:462–467
Blevins JE, Morton GJ, Williams DL et al (2009) Forebrain melanocortin signaling enhances the hindbrain satiety response to CCK-8. Am J Physiol Regul Integr Comp Physiol 296:R476–R484
Blouet C, Jo YH, Li X et al (2009) Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus–brainstem circuit. J Neurosci 29:8302–8311
Bong HY, Kim JY, Jeong HI et al (2010) Effects of corn gluten hydrolyzates, branched chain amino acids, and leucine on body weight reduction in obese rats induced by a high fat diet. Nutr Res Pract 4:106–113
Bucinskaite V, Tolessa T, Pedersen J et al. (2009) Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroent Motil 21
Chen Q, Reimer RA (2009) Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro. Nutrition 25:340–349
Cheng Y, Meng Q, Wang C et al (2010) Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (UCP1) in brown adipose tissue. Diabetes 59:17–25
Cheng Y, Zhang Q, Meng Q et al (2011) Leucine deprivation stimulates fat loss via increasing CRH expression in the hypothalamus and activating the sympathetic nervous system. Mol Endocrinol 25:1624–1635
Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8:571–578
Cota D, Proulx K, Smith KA et al (2006) Hypothalamic mTOR signaling regulates food intake. Science 312:927–930
Cowley MA, Smart JL, Rubinstein M et al (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480–484
Cowley MA, Smith RG, Diano S et al (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649–661
Cummings DE, Weigle DS, Frayo RS et al (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630
Date Y, Kojima M, Hosoda H et al (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255–4261
Date Y, Murakami N, Toshinai K et al (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123:1120–1128
Deschenes RJ, Lorenz LJ, Haun RS et al (1984) Cloning and sequence analysis of a cDNA-encoding rat preprocholecystokinin. P Natl Acad Sci-Biol 81:726–730
Devkota S, Layman DK (2010) Protein metabolic roles in treatment of obesity. Curr Opin Clin Nutr 13:403–407
Diraison F, Yankah V, Letexier D et al (2003) Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans. J Lipid Res 44:846–853
Donato J Jr, Pedrosa RG, Cruzat VF et al (2006) Effects of leucine supplementation on the body composition and protein status of rats submitted to food restriction. Nutrition 22:520–527
Dube MG, Xu B, Crowley WR et al (1994) Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res 646:341–344
Egecioglu E, Stenstrom B, Pinnock SB et al (2008) Hypothalamic gene expression following ghrelin therapy to gastrectomized rodents. Regul Pept 146:176–182
Enriori PJ, Evans AE, Sinnayah P et al (2007) Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab 5:181–194
Fan W, Boston BA, Kesterson RA et al (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165–168
Gibbs J, Young RC, Smith GP (1973) Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245:323–325
Gutzwiller JP, Goke B, Drewe J et al (1999) Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 44:81–86
Hatakeyama Y, Sakata Y, Takakura S et al (2004) Acute and chronic effects of FR-149175, a beta(3)-adrenergic receptor agonist, on energy expenditure in Zucker fatty rats. Am J Physiol-Reg I 287:R336–R341
Huang XF, Han M, South T et al (2003) Altered levels of POMC, AgRP and MC4-R mRNA expression in the hypothalamus and other parts of the limbic system of mice prone or resistant to chronic high-energy diet-induced obesity. Brain Res 992:9–19
Joseph SA, Michael GJ (1988) Efferent Acth-Ir opiocortin projections from nucleus tractus solitarius—a hypothalamic deafferentation study. Peptides 9:193–201
Leenders M, Verdijk LB, van der Hoeven L et al (2011) Prolonged leucine supplementation does not augment muscle mass or affect glycemic control in elderly type 2 diabetic men. J Nutr 141:1070–1076
Li FN, Yin YL, Tan B et al (2011) Leucine nutrition in animals and humans: mTOR signaling and beyond. Amino Acids 41:1185–1193
Luckman SM, Lawrence CB (2003) Anorectic brainstem peptides: more pieces to the puzzle. Trends Endocrin Met 14:60–65
Lynch CJ (2001) Role of leucine in the regulation of mTOR by amino acids: revelations from structure–activity studies. J Nutr 131:861S–865S
Macotela Y, Emanuelli B, Bang AM et al (2011) Dietary leucine—an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One 6:e21187
Mano-Otagiri A, Iwasaki-Sekino A, Nemoto T et al (2010) Genetic suppression of ghrelin receptors activates brown adipocyte function and decreases fat storage in rats. Regul Pept 160:81–90
Mashiko S, Ishihara A, Iwaasa H et al (2007) A pair-feeding study reveals that a Y5 antagonist causes weight loss in diet-induced obese mice by modulating food intake and energy expenditure. Mol Pharmacol 71:602–608
Mizuno TM, Kleopoulos SP, Bergen HT et al (1998) Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47:294–297
Moran TH, Baldessarini AR, Salorio CF et al (1997) Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. Am J Physiol 272:R1245–R1251
Nairizi A, She P, Vary TC et al (2009) Leucine supplementation of drinking water does not alter susceptibility to diet-induced obesity in mice. J Nutr 139:715–719
Naslund E, Barkeling B, King N et al (1999) Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord 23:304–311
Nilaweera KN, Giblin L, Ross RP (2010) Nutrient regulation of enteroendocrine cellular activity linked to cholecystokinin gene expression and secretion. J Physiol Biochem 66:85–92
Noatsch A, Petzke KJ, Millrose MK et al. (2010) Body weight and energy homeostasis was not affected in C57BL/6 mice fed high whey protein or leucine-supplemented low-fat diets. Eur J Nutr
Nogueiras R, Perez-Tilve D, Veyrat-Durebex C et al (2009) Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity. J Neurosci 29:5916–5925
Nogueiras R, Wiedmer P, Perez-Tilve D et al (2007) The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 117:3475–3488
Norton LE, Layman DK, Bunpo P et al (2009) The leucine content of a complete meal directs peak activation but not duration of skeletal muscle protein synthesis and mammalian target of rapamycin signaling in rats. J Nutr 139:1103–1109
Osaka T, Endo M, Yamakawa M et al (2005) Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system. Peptides 26:1623–1631
Pankevich DE, Teegarden SL, Hedin AD et al (2010) Caloric restriction experience reprograms stress and orexigenic pathways and promotes binge eating. J Neurosci 30:16399–16407
Qin LQ, Xun P, Bujnowski D et al (2011) Higher branched-chain amino acid intake is associated with a lower prevalence of being overweight or obese in middle-aged East Asian and Western adults. J Nutr 141:249–254
Raposinho PD, Pierroz DD, Broqua P et al (2001) Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6 J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Mol Cell Endocrinol 185:195–204
Richard CD, Tolle V, Low MJ (2011) Meal pattern analysis in neural-specific proopiomelanocortin-deficient mice. Eur J Pharmacol 660:131–138
Ropelle ER, Pauli JR, Fernandes MF et al (2008) A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss. Diabetes 57:594–605
Roseberry AG, Liu H, Jackson AC et al (2004) Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 41:711–722
Savastano DM, Covasa M (2005) Adaptation to a high-fat diet leads to hyperphagia and diminished sensitivity to cholecystokinin in rats. J Nutr 135:1953–1959
Schelbert KB (2009) Comorbidities of obesity. Prim Care 36:271–285
Seo S, Ju S, Chung H et al (2008) Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats. Endocr J 55:867–874
Sun X, Zemel MB (2007) Leucine and calcium regulate fat metabolism and energy partitioning in murine adipocytes and muscle cells. Lipids 42:297–305
Suominen AH, Glimm DR, Tedesco D et al (1998) Intestinal nutrient-gene interaction: the effect of feed deprivation and refeeding on cholecystokinin and proglucagon gene expression. J Anim Sci 76:3104–3113
Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908–913
Tucker JD, Dhanvantari S, Brubaker PL (1996) Proglucagon processing in islet and intestinal cell lines. Regul Pept 62:29–35
van Loon LJC (2012) Leucine as a pharmaconutrient in health and disease. Curr Opin Clin Nutr 15:71–77
Verhoeven S, Vanschoonbeek K, Verdijk LB et al (2009) Long-term leucine supplementation does not increase muscle mass or strength in healthy elderly men. Am J Clin Nutr 89:1468–1475
Vianna D, Resende GF, Torres-Leal FL et al (2012) Long-term leucine supplementation reduces fat mass gain without changing body protein status of aging rats. Nutrition 28:182–189
Walzem RL, Dillard CJ, German JB (2002) Whey components: millennia of evolution create functionalities for mammalian nutrition: what we know and what we may be overlooking. Crit Rev Food Sci Nutr 42:353–375
Wren AM, Seal LJ, Cohen MA et al (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
Xu G, Li Y, An W et al (2009) Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake. Endocrinology 150:3637–3644
Yasuda T, Masaki T, Kakuma T et al (2004) Hypothalamic melanocortin system regulates sympathetic nerve activity in brown adipose tissue. Exp Biol Med (Maywood) 229:235–239
Yin Y, Yao K, Liu Z et al (2010) Supplementing L-leucine to a low-protein diet increases tissue protein synthesis in weanling pigs. Amino Acids 39:1477–1486
Zeanandin G, Balage M, Schneider SM et al (2012) Differential effect of long-term leucine supplementation on skeletal muscle and adipose tissue in old rats: an insulin signaling pathway approach. Age (Dordr) 34:371–387
Zhang Y, Guo K, LeBlanc RE et al (2007) Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 56:1647–1654
Zhang YY, Proenca R, Maffei M et al (1994) Positional cloning of the mouse obese gene and its human homolog. Nature 372:425–432
Acknowledgments
The on-going work in the area of nutrient effects on energy balance is funded by Teagasc, Ireland. The authors have no conflicts of interest. Each author listed contributed by reviewing the literature and/or by critically reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McAllan, L., Cotter, P.D., Roche, H.M. et al. Impact of leucine on energy balance. J Physiol Biochem 69, 155–163 (2013). https://doi.org/10.1007/s13105-012-0170-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-012-0170-2